Holen Sie sich die Stockscreener-App
3.38
4.79%
-0.17
Handel nachbörslich:
3.20
-0.18
-5.33%
Allurion Technologies Inc Aktie (ALUR) Neueste Nachrichten
Allurion to raise $6.1 million in direct offering and private placement - MSN
Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline - Business Wire
Allurion announces $6.1 million stock and warrant sale - Investing.com
Allurion Tech dips on $6.1 million stock offering - TradingView
S&P 500 Edges Higher; Analog Devices Earnings Top Views - Benzinga
Allurion Technologies Expects to Raise $6.1 Million From Stock Offering; Shares Plunge - Marketscreener.com
Dow Dips 150 Points; US Housing Starts Fall In January - Benzinga
Allurion to sell 900,000 shares at $5.23 in registered direct offering - TipRanks
Allurion announces $6.1 million stock and warrant sale By Investing.com - Investing.com UK
Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline - Business Wire
Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity - BioSpace
Allurion stock soars 70% on weight-loss therapy update - MSN
Allurion to study balloon and GLP-1 therapy combo - Investing.com
Allurion to study balloon and GLP-1 therapy combo By Investing.com - Investing.com South Africa
Allurion Technologies to initiate Allurion Balloon with GLP-1 agonists study - TipRanks
Allurion cleared to resume sale of swallowable gastric balloon in France - BioWorld Online
ALURAllurion Relaunches in France - ADVFN Logo
Allurion Technologies relaunches in France - TipRanks
ANSM Clears Allurion To Resume Sales Of Allurion Balloon -February 13, 2025 at 08:40 am EST - Marketscreener.com
Allurion Relaunches in France - Business Wire
Allurion Technologies Touts Positive Study Results for its Weight Loss Balloon - MPO-mag
How Much Upside is Left in Allurion Technologies, Inc. (ALUR)? Wall Street Analysts Think 374.67% - MSN
Allurion announces study on obesity treatment enhancement - MSN
12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session - Benzinga
This Little-Known Stock Just Doubled on Weight-Loss Drug News. Analysts Think It Has 400% Upside Potential From Here. - MSN
Eli Lilly and Company (LLY-N) QuotePress Release - The Globe and Mail
11 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session - Benzinga
Allurion Technologies Soars 200% Amid Stock Offering and New Clinical Study Plans for Weight Loss Product - HPBL
Allurion Technologies Shares Surge as Company Eyes Obesity Drug Market with Gastric Balloon-GLP-1 Combo - HPBL
Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Allurion extends rally despite $7.4M stock and warrants offering - MSN
Allurion Soared Over 200% Today, But Is The Weight-Loss Stock A Buy? - Barchart
Allurion Catapults 200% On Its Plans To Outdo Eli Lilly, Novo Nordisk - MSN
Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk - Yahoo! Voices
Allurion Technologies Shares Are Up Today: What's Going On? - Benzinga
Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs - MSN
Allurion shares soar 77% after sharing plans for GLP-1RA combo trial - Yahoo Finance
Allurion Technologies Launches Stock Offering To Boost Growth - Evrim Ağacı
Allurion Technologies stock soars on clinical study announcement - MSN
Dow Falls 100 Points; US Manufacturing PMI Rises In January - Benzinga
Allurion Stock Explodes Following Clinical Study Announcement - Wall Street Pit
Allurion Shares Surge 185% Following $7.4 Million Fundraising Announcement - Yahoo Finance
Investors Are Buzzing! Major Breakthrough in Weight Loss Technology! - Jomfruland.net
Allurion Stock Skyrockets 80% After Hours Following Clinical Study Announcement - Yahoo Finance
Allurion Technologies' Stock Soars After Clinical Study Announcement - Evrim Ağacı
US Stocks Mixed; Verizon Posts Upbeat Sales - Benzinga
Allurion Technologies to sell 1.24M shares at $6 in registered direct offering - TipRanks
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market - The Bakersfield Californian
1.10%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):